We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review
Summary
This review examined the lipidome as a regulator of lipid metabolism in the gastrointestinal tract and proposed that lipid-protein interactions and lipoprotein transport pathways may play a protective role during COVID-19, with implications for understanding disease severity in metabolically vulnerable individuals.
The term lipidome is mentioned to the total amount of the lipids inside the biological cells. The lipid enters the human gastrointestinal tract through external source and internal source. The absorption pathway of lipids in the gastrointestinal tract has many ways; the 1st way, the lipid molecules are digested in the lumen before go through the enterocytes, digested products are re-esterified into complex lipid molecules. The 2nd way, the intracellular lipids are accumulated into lipoproteins (chylomicrons) which transport lipids throughout the whole body. The lipids are re-synthesis again inside the human body where the gastrointestinal lipids are: (1) Transferred into the endoplasmic reticulum; (2) Collected as lipoproteins such as chylomicrons; or (3) Stored as lipid droplets in the cytosol. The lipids play an important role in many stages of the viral replication cycle. The specific lipid change occurs during viral infection in advanced viral replication cycle. There are 47 lipids within 11 lipid classes were significantly disturbed after viral infection. The virus connects with blood-borne lipoproteins and apolipoprotein E to change viral infectivity. The viral interest is cholesterol- and lipid raft-dependent molecules. In conclusion, lipidome is important in gastrointestinal fat absorption and coronavirus disease 2019 (COVID-19) infection so lipidome is basic in gut metabolism and in COVID-19 infection success.
Sign in to start a discussion.
More Papers Like This
Contributing factors common to COVID‑19 and gastrointestinal cancer
This review identifies contributing factors common to COVID-19 vulnerability and gastrointestinal cancer risk, including gut microbiome dysbiosis, dietary patterns, and chronic inflammation, suggesting that immune dysfunction driven by environmental and lifestyle factors underlies susceptibility to both conditions.
Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
Researchers identified unique lipid signatures in blood plasma that distinguish aortic dissection patients from healthy controls using lipidomics, revealing potential biomarkers for improved risk assessment of this cardiovascular emergency.
Lipid Corona Formation on Micro- and Nanoplastic Particles Modulates Uptake and Toxicity in A549 Cells
Researchers found that lipid corona formation on micro- and nanoplastic particles significantly modulates their cellular uptake and toxicity in human lung cells, suggesting that biological coatings alter how plastic particles interact with human tissues.
Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity
This review examines how nanotechnology-based approaches can regulate lipid metabolism in tumor microenvironments to enhance anti-cancer immune responses, covering lipid nanoparticles, liposomes, and other delivery systems. The authors identify lipid metabolic reprogramming as a promising immunotherapy target and nanotechnology as a key enabler for delivering therapeutics that reshape tumor-associated metabolic pathways.
[Effect of microand nanoplastics on the gastrointestinal mucosa and intestinal microbiome].
This review examines how micro- and nanoplastics entering through the food chain affect the gastrointestinal tract, finding evidence of disruption to gut mucosal integrity and intestinal microbiome composition, with implications for digestive health and systemic immune function.